Protein language models predict artemisinin partial resistance and prioritize genetic modifiers in Plasmodium falciparum
Preprint
- 23 September 2026
- preprint
- Published by Springer Nature in Research Square
Abstract
Artemisinin partial resistance threatens malaria control, but molecular surveillance relies largely on established K13 variants, limiting interpretation of emerging sequence variation. Here we used ESM-3 protein representations to model resistance in 1,293 Plasmodium falciparum clinical isolates. K13 sequence models generalized across temporally independent cohorts (auROC > 0.88; auPR > 0.83) and retained predictive information for geographically distinct and previously unseen K13 substitutions, correctly classifying 13 of 17 variants absent from training. Extending the framework to 167 ART-R-associated candidate genes recovered established resistance loci and provided complementary predictive information to training-selected single-variant markers. Model-based prioritization identified EXO E415G, and CRISPR–Cas9 editing showed that E415G increased ring-stage survival only in parasites carrying K13 C580Y, whereas ATP4 G1128R had no measurable effect. These findings establish protein-sequence modeling as a complementary approach for prioritizing emerging resistance-associated variation and context-dependent genetic modifiers.Keywords
All Related Versions
This publication has 55 references indexed in Scilit:
- Selection of Plasmodium falciparum kelch13 mutations in Uganda in comparison with southeast Asia: a modelling studyThe Lancet Microbe, 2025
- Peeling the onion: how complex is the artemisinin resistance genetic trait of malaria parasites?Trends in Parasitology, 2024
- Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistanceThe Lancet Infectious Diseases, 2024
- The emergence of artemisinin partial resistance in Africa: how do we respond?The Lancet Infectious Diseases, 2024
- 15 years of GWAS discovery: Realizing the promiseThe American Journal of Human Genetics, 2023
- Machine learning for artemisinin resistance in malaria treatment across in vivo-in vitro platformsiScience, 2022
- Integration of population and functional genomics to understand mechanisms of artemisinin resistance in Plasmodium falciparumInternational Journal for Parasitology: Drugs and Drug Resistance, 2021
- Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology studyThe Lancet Infectious Diseases, 2019
- Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic studyThe Lancet Infectious Diseases, 2018
- Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype–phenotype association studyThe Lancet Infectious Diseases, 2017